SCHEMBL14558182

SCHEMBL14558182

CN(C)c1cccc(Nc2cc(Cl)ncn2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.71
EGFR P00533 10/20 0.50
ERBB3 P21860 2/20 0.47
KDM1A O60341 1/20 0.46
TNNI3K Q59H18 5/20 0.43
MKNK1 Q9BUB5 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
RAB9A P51151 1/20 0.43
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
GLA P06280 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL374904 0.84 TNNI3K (0.57) NPC1EGFRERBB3KDM1ATNNI3K
SCHEMBL374166 0.84 EGFR (0.61) NPC1EGFRERBB3KDM1ATNNI3K
SCHEMBL2279629 0.80 EGFR (0.59) NPC1EGFRERBB3TNNI3KMKNK1
SCHEMBL3952295 0.80 EGFR (0.66) NPC1EGFRERBB3TNNI3KMKNK1
SCHEMBL691972 0.78 NPC1 (0.48) NPC1EGFRERBB3TNNI3KMKNK1
Hydrochloric Acid SCHEMBL2173883 0.78 EGFR (0.64) NPC1EGFRERBB3TNNI3KMKNK1
SCHEMBL374014 0.78 EGFR (0.66) NPC1EGFRERBB3MEN1KMT2A
SCHEMBL857502 0.77 NPC1 (0.63) NPC1EGFRERBB3TNNI3KMKNK1
SCHEMBL691533 0.77 EGFR (0.57) NPC1EGFRERBB3TNNI3K
SCHEMBL20093470 0.77 NPC1 (0.51) NPC1EGFRERBB3TNNI3KMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189729-B2 Methods and compositions as protein kinase inhibitors IRM LLC (BM) 2007-03-13 US disclosed
US-7189729-B2 Methods and compositions as protein kinase inhibitors IRM LLC (BM) 2007-03-13 US disclosed